A recent study by Hult et al.[18] even established a causal link between mutant huntingtin expression in the hypothalamus and metabolic dysfunctions, and suggested that metabolic parameters are powerful readouts for assessing HD therapies. This evidence concerns the gene HTT and Huntington disease.